Condition
Idiopathic Interstitial Pneumonias
Total Trials
6
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 2 (1)
Trial Status
Terminated2
Recruiting1
Enrolling By Invitation1
Active Not Recruiting1
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT05365802Early Phase 1Recruiting
FAPI PET for Lung Fibrosis
NCT03747627Active Not Recruiting
BPF Genetics of ILD Study
NCT04896138Enrolling By Invitation
University of Virginia Natural History Study
NCT03142191Phase 2Terminated
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
NCT04511884Unknown
Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid
NCT01151527TerminatedPrimary
Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Showing all 6 trials